Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 7/20 | 0.64 |
| ▸ | CDK9 | P50750 | 7/20 | 0.64 |
| ▸ | CDK5R1 | Q15078 | 6/20 | 0.64 |
| ▸ | CCNT1 | O60563 | 6/20 | 0.64 |
| ▸ | CCNA2 | P20248 | 6/20 | 0.64 |
| ▸ | CDK2 | P24941 | 6/20 | 0.64 |
| ▸ | CCNA1 | P78396 | 5/20 | 0.64 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.64 |
| ▸ | PRKCI | P41743 | 2/20 | 0.58 |
| ▸ | BRAF | P15056 | 1/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.53 |
| ▸ | JAK2 | O60674 | 2/20 | 0.53 |
| ▸ | PRKACA | P17612 | 2/20 | 0.53 |
| ▸ | JAK3 | P52333 | 2/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.53 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.53 |
| ▸ | IKBKB | O14920 | 1/20 | 0.53 |
| ▸ | CHUK | O15111 | 1/20 | 0.53 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22620120 | 0.83 | CCNT1 (0.52) | CDK5CDK9CDK5R1CCNT1CCNA2 | |
| SCHEMBL1719341 | 0.81 | PRKCI (0.63) | CDK5CDK9CDK5R1CCNT1CCNA2 | |
| SCHEMBL12354979 | 0.81 | PRKCI (0.58) | CDK5CDK9CDK2PRKCIBRAF | |
| SCHEMBL12347396 | 0.81 | BRAF (0.60) | CDK5CDK9CDK2PRKCIBRAF | |
| SCHEMBL3255183 | 0.81 | PRKCI (0.58) | CDK5CDK9CDK2PRKCIBRAF | |
| SCHEMBL16113151 | 0.79 | PRKCI (0.59) | CDK5CDK9CDK2PRKCIBRAF | |
| SCHEMBL2240671 | 0.78 | AURKB (0.71) | CDK5CDK9CDK2PRKCIDYRK1A | |
| SCHEMBL2238760 | 0.78 | BRAF (0.61) | CDK5CDK9CDK5R1CCNT1CCNA2 | |
| Meriolin 1 SCHEMBL2241315 | 0.78 | CDK9 (1.00) | CDK5CDK9CDK5R1CCNT1CCNA2 | |
| SCHEMBL3615777 | 0.78 | GSK3B (0.67) | CDK5CDK9CDK5R1CCNT1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2011526931-A | — | — | 2011-10-20 | — | — | JP | claimed |
| US-20110201599-A1 | CDK Modulators | EXELIXIS, INC. (US) | 2011-08-18 | — | — | US | claimed |
| CN-102143746-A | CDK modulators | EXELIXIS INC | 2011-08-03 | — | — | CN | claimed |
| EP-2320895-A2 | CDK MODULATORS | Exelixis, Inc. (US) | 2011-05-18 | — | — | EP | claimed |
| WO-2010003133-A2 | CDK MODULATORS | EXELIXIS INC. (US) | 2010-01-07 | — | — | WO | claimed |
| US-20110201599-A1 | CDK Modulators | EXELIXIS, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| US-20110201599-A1 | CDK Modulators | EXELIXIS, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| US-20110201599-A1 | CDK Modulators | EXELIXIS, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| CN-102143746-A | CDK modulators | EXELIXIS INC | 2011-08-03 | — | — | CN | disclosed |
| WO-2010003133-A2 | CDK MODULATORS | EXELIXIS INC. (US) | 2010-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201599-A1 | CDK Modulators | CDK3, CDK1, CDKL1 | CDK5 24/4885CDK9 6/4885CDK5R1 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.